Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 35


Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.

Liu J, Rao J, Lou X, Zhai J, Ni Z, Wang X.

Cell Physiol Biochem. 2017;44(1):255-266. doi: 10.1159/000484678. Epub 2017 Nov 9.


TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells.

Zhang Z, Xu C, Zhang X, Huang L, Zheng C, Chen H, Wang Y, Ju H, Yao Q.

Oncol Res. 2017 May 24;25(5):691-699. doi: 10.3727/096504016X14774897404770. Epub 2016 Dec 15.


High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.

Chen Y, Li L, Qian X, Ge Y, Xu G.

Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):190-196. doi: 10.1016/j.clinre.2016.09.010. Epub 2017 Jan 5.


TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells.

Wang X, Shi W, Shi H, Lu S, Wang K, Sun C, He J, Jin W, Lv X, Zou H, Shu Y.

J Exp Clin Cancer Res. 2016 Jun 21;35(1):100. doi: 10.1186/s13046-016-0379-y.


TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.

Di K, Linskey ME, Bota DA.

Oncogene. 2013 Oct 17;32(42):5038-47. doi: 10.1038/onc.2012.531. Epub 2012 Nov 26.


Cutaneous Melanocytoma With CRTC1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell Sarcoma.

Cellier L, Perron E, Pissaloux D, Karanian M, Haddad V, Alberti L, de la Fouchardière A.

Am J Surg Pathol. 2018 Mar;42(3):382-391. doi: 10.1097/PAS.0000000000000996.


TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer.

Yin Y, Zhong J, Li SW, Li JZ, Zhou M, Chen Y, Sang Y, Liu L.

Oncotarget. 2016 Dec 27;7(52):86755-86765. doi: 10.18632/oncotarget.13550.


An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating.

Yuan T, Yao W, Tokunaga K, Yang R, Sun B.

Retrovirology. 2016 Oct 13;13(1):72.


The human antiviral factor TRIM11 is under the regulation of HIV-1 Vpr.

Yuan T, Yao W, Huang F, Sun B, Yang R.

PLoS One. 2014 Aug 8;9(8):e104269. doi: 10.1371/journal.pone.0104269. eCollection 2014.


The E3 ubiquitin ligase TRIM11 mediates the degradation of congenital central hypoventilation syndrome-associated polyalanine-expanded PHOX2B.

Parodi S, Di Zanni E, Di Lascio S, Bocca P, Prigione I, Fornasari D, Pennuto M, Bachetti T, Ceccherini I.

J Mol Med (Berl). 2012 Sep;90(9):1025-35. doi: 10.1007/s00109-012-0868-1. Epub 2012 Feb 4.


TRIM11 binds to and destabilizes a key component of the activator-mediated cofactor complex (ARC105) through the ubiquitin-proteasome system.

Ishikawa H, Tachikawa H, Miura Y, Takahashi N.

FEBS Lett. 2006 Sep 4;580(20):4784-92. Epub 2006 Aug 4.


Gene by stress genome-wide interaction analysis and path analysis identify EBF1 as a cardiovascular and metabolic risk gene.

Singh A, Babyak MA, Nolan DK, Brummett BH, Jiang R, Siegler IC, Kraus WE, Shah SH, Williams RB, Hauser ER.

Eur J Hum Genet. 2015 Jun;23(6):854-62. doi: 10.1038/ejhg.2014.189. Epub 2014 Oct 1.


A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insults.

Niikura T, Hashimoto Y, Tajima H, Ishizaka M, Yamagishi Y, Kawasumi M, Nawa M, Terashita K, Aiso S, Nishimoto I.

Eur J Neurosci. 2003 Mar;17(6):1150-8.


TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.

Lee Y, Song B, Park C, Kwon KS.

PLoS One. 2013 May 13;8(5):e63255. doi: 10.1371/journal.pone.0063255. Print 2013.


Trim11 increases expression of dopamine beta-hydroxylase gene by interacting with Phox2b.

Hong SJ, Chae H, Lardaro T, Hong S, Kim KS.

Biochem Biophys Res Commun. 2008 Apr 11;368(3):650-5. doi: 10.1016/j.bbrc.2008.01.165. Epub 2008 Feb 12.


TRIM11 Suppresses AIM2 Inflammasome by Degrading AIM2 via p62-Dependent Selective Autophagy.

Liu T, Tang Q, Liu K, Xie W, Liu X, Wang H, Wang RF, Cui J.

Cell Rep. 2016 Aug 16;16(7):1988-2002. doi: 10.1016/j.celrep.2016.07.019. Epub 2016 Aug 4.


Candidate-gene testing for orphan limb-girdle muscular dystrophies.

Aurino S, Piluso G, Saccone V, Cacciottolo M, D'Amico F, Dionisi M, Totaro A, Belsito A, Di Vicino U, Nigro V.

Acta Myol. 2008 Dec;27:90-7.


TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14.

Chen L, Zhu G, Johns EM, Yang X.

Nat Commun. 2018 Mar 26;9(1):1223. doi: 10.1038/s41467-018-03499-z.

Supplemental Content

Support Center